Elsa's AI Model Migration: Technical, Compliance, And Regulatory Risks For Sponsors (Part 2)By Kimberly Chew, Esq., and Michael Yang, Esq. The compliance landscape for Elsa is shifting along with its underlying AI model. Sponsor-Focused Risk Assessment ChecklistGiven the complexity and uncertainty of Elsa’s migration, sponsors should proactively assess their risk exposure. Has the new AI model been fully validated for your specific use case? Chris Mazzolini & Mike Hollan, “FDA’s Elsa AI Tool Raises Accuracy and Oversight Concerns,” Applied Clinical Trials (July 23, 2025), https://www.appliedclinicaltrialsonline.com/view/fda-elsa-ai-tool-raises-accuracy-and-oversight-concerns.

Source: CNN March 26, 2026 05:47 UTC